Autonomic Nervous System Drugs Practice Questions

Q: Which of the following anticholinesterase agents is derived from a natural source?

Physostigmine. ### Explanation **Correct Option: A. Physostigmine** Physostigmine is a naturally occurring alkaloid obtained from the dried seeds of the **Calabar bean** (*Physostigma venenosum*). Chemically, it is a tertiary amine, which makes it lipid-soluble. This property allows it to cross the blood-brain barrier (BBB) and exert both peripheral and central effects. It is primarily used as an antidote for atropine poisoning. **Analysis of Incorrect Options:** * **B. Neostigmine:** This is a **synthetic** quaternary ammonium compound. Unlike physostigmine, it is polar and does not cross the BBB. It is commonly used for Myasthenia Gravis and reversing neuromuscular blockade. * **C. Pyridostigmine:** This is also a **synthetic** quaternary ammonium analog of neostigmine. It has a longer duration of action and is the preferred maintenance drug for Myasthenia Gravis. * **D. Tacrine:** This is a **synthetic** centrally acting reversible anticholinesterase. It was the first drug approved for Alzheimer’s disease but is now rarely used due to significant hepatotoxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Lipid Solubility Rule:** Tertiary amines (Physostigmine, Rivastigmine, Donepezil) cross the BBB; Quaternary amines (Neostigmine, Pyridostigmine, Edrophonium) do not. * **Drug of Choice (DOC):** Physostigmine is the DOC for **Atropine/Belladonna poisoning**. * **Glaucoma:** Physostigmine was historically used topically to treat glaucoma (miotic), though it has largely been replaced by newer agents. * **Organophosphate Poisoning:** Remember that anticholinesterases like Physostigmine are *reversible*, whereas organophosphates are *irreversible* inhibitors.

Q: Which of the following is a selective α2 agonist?

Clonidine. **Explanation:** **Clonidine** is the correct answer because it is a prototype **selective α2-adrenergic agonist**. It acts primarily on presynaptic α2 receptors in the brainstem (vasomotor center), leading to a decrease in sympathetic outflow. This reduction in norepinephrine release results in decreased peripheral vascular resistance and blood pressure. **Analysis of Incorrect Options:** * **Prazosin:** This is a selective **α1-blocker** (antagonist). It is primarily used in the treatment of hypertension and Benign Prostatic Hyperplasia (BPH) by causing vasodilation and relaxing prostatic smooth muscle. * **Adrenaline (Epinephrine):** This is a **non-selective adrenergic agonist** that acts on α1, α2, β1, and β2 receptors. Its effects are dose-dependent and widespread across the sympathetic nervous system. * **Propranolol:** This is a **non-selective β-blocker** (antagonist) that blocks both β1 and β2 receptors. It is used for hypertension, prophylaxis of migraine, and performance anxiety. **High-Yield Clinical Pearls for NEET-PG:** * **Other α2 Agonists:** Methyldopa (drug of choice for hypertension in pregnancy), Dexmedetomidine (used for sedation in ICU), and Tizanidine (centrally acting muscle relaxant). * **Side Effects of Clonidine:** Dry mouth (xerostomia), sedation, and most importantly, **rebound hypertension** if the drug is stopped abruptly. * **Diagnostic Use:** The Clonidine Suppression Test is used in the diagnosis of Pheochromocytoma (failure to suppress plasma catecholamines).

Q: Which of the following cholinomimetics activates both muscarinic and nicotinic receptors?

Carbachol. **Explanation:** The question tests your knowledge of the receptor selectivity of direct-acting cholinomimetics (choline esters and alkaloids). **Why Carbachol is Correct:** Carbachol is a choline ester that lacks selectivity; it is a potent agonist at **both muscarinic (M) and nicotinic (N) receptors**. Structurally, it is a carbamic acid ester of choline, making it resistant to hydrolysis by acetylcholinesterase (AChE). Because it stimulates nicotinic receptors at the autonomic ganglia, it can cause complex cardiovascular effects, though its primary clinical use today is topical (miotic) for glaucoma. **Analysis of Incorrect Options:** * **Methacholine (A):** This is a modified analog of acetylcholine with a methyl group on the beta-carbon. This modification makes it **highly selective for muscarinic receptors** with almost negligible nicotinic activity. It is primarily used in the "Methacholine Challenge Test" for diagnosing bronchial hyperreactivity. * **Bethanechol (B):** Like methacholine, it has a beta-methyl group which confers **pure muscarinic selectivity**. It also has a carbamate group, making it resistant to AChE. It is used clinically to treat postoperative urinary retention and paralytic ileus. * **Pilocarpine (C):** This is a natural alkaloid. It is a **selective muscarinic agonist** and lacks nicotinic activity. It is a tertiary amine (can cross the BBB) and is a potent diaphoretic and miotic. **High-Yield NEET-PG Pearls:** * **Mnemonic for Selectivity:** **B**ethanechol and **M**ethacholine are **M**uscarinic only. * **Resistance to AChE:** Carbachol and Bethanechol are resistant to AChE due to the carbamate group, giving them a longer duration of action than Acetylcholine or Methacholine. * **Clinical Use:** Carbachol is used in the treatment of glaucoma and to produce miosis during ocular surgery.

Q: Non-selective beta-blockers are contraindicated in patients with diabetes due to which of the following reasons?

Hypoglycemic unawareness. ### Explanation **1. Why Hypoglycemic Unawareness is Correct:** In diabetic patients, hypoglycemia (often caused by insulin or sulfonylureas) triggers a sympathetic "fight-or-flight" response. This results in warning signs like **tachycardia, palpitations, and tremors**, mediated by $\beta_1$ and $\beta_2$ receptors. Non-selective beta-blockers (e.g., Propranolol) block these receptors, masking these vital warning signs. Consequently, the patient may slide into a life-threatening hypoglycemic coma without realizing their blood glucose has dropped. This phenomenon is known as **hypoglycemic unawareness**. **2. Analysis of Incorrect Options:** * **A. Hyperglycemia:** Beta-blockers actually carry a risk of **hypoglycemia** (not hyperglycemia) because $\beta_2$ receptors are responsible for hepatic glycogenolysis and gluconeogenesis. Blocking them prevents the liver from releasing glucose during a crisis. * **C. Tachycardia:** While beta-blockers cause bradycardia, this is the *mechanism* of masking, not the *reason* for contraindication. The danger lies in the patient not feeling the tachycardia that should signal low blood sugar. * **D. Hypotension:** While beta-blockers can lower blood pressure, this is a therapeutic effect or a general side effect, not the specific reason they are contraindicated in diabetes. **3. High-Yield NEET-PG Pearls:** * **Sweating:** This is the only sympathetic symptom of hypoglycemia **not blocked** by beta-blockers, as it is mediated by **cholinergic** fibers (muscarinic receptors). * **Selective Beta-blockers:** Cardioselective ($\beta_1$) blockers like **Atenolol or Metoprolol** are preferred in diabetics if a beta-blocker is mandatory, as they have less effect on glucose metabolism and $\beta_2$-mediated symptoms. * **Delayed Recovery:** Non-selective blockers also delay recovery from hypoglycemia by inhibiting $\beta_2$-mediated compensatory glucose release.

Q: Which of the following is the most reliable clinical endpoint to indicate adequate atropinization in organophosphorus poisoning?

Absence of pulmonary secretions. ### Explanation In Organophosphorus (OP) poisoning, death typically occurs due to **respiratory failure** caused by excessive bronchial secretions (bronchorrhea) and bronchoconstriction. Atropine is a competitive muscarinic antagonist used to reverse these life-threatening cholinergic effects [3]. **Why "Absence of pulmonary secretions" is the correct answer:** The primary goal of atropinization is to ensure a clear airway. **Drying of pulmonary secretions** (clear breath sounds on auscultation) is the most reliable and critical clinical endpoint because it directly correlates with the reversal of the most lethal complication of OP poisoning [3]. Once the lungs are clear, the dose of atropine can be titrated to a maintenance level. **Analysis of Incorrect Options:** * **A. Pupillary dilation (Mydriasis):** While atropine causes mydriasis, it is an unreliable indicator. Pupils may remain constricted due to local OP exposure in the eyes or may dilate before the lungs are clear. * **B. Control of diarrhea:** Gastrointestinal motility is one of the last symptoms to resolve and is not life-threatening [2]; relying on this would lead to over-atropinization. * **C. Heart rate $\geq$ 100 bpm:** Tachycardia is a sign of atropine action, but it can be misleading. In some OP poisoning cases, nicotinic effects can cause initial tachycardia, making it an inconsistent marker for muscarinic blockade. **Clinical Pearls for NEET-PG:** * **Atropinization Targets:** The "Big Three" signs are **Clear breath sounds** (most important), **Heart rate >80-100 bpm**, and **Systolic BP >80 mmHg**. * **Atropine does NOT** reverse nicotinic effects (muscle fasciculations or paralysis); for this, **Oximes** (e.g., Pralidoxime) are required [1], [4]. * **Atropine Flush:** High doses may cause cutaneous vasodilation, hyperpyrexia, and delirium ("Mad as a hatter, Red as a beet, Dry as a bone").

Q: Conversion of norepinephrine to epinephrine occurs by which process?

Methylation. **Explanation:** The conversion of **Norepinephrine (NE) to Epinephrine (Epi)** occurs primarily in the adrenal medulla through the process of **Methylation**. 1. **Why Methylation is Correct:** The specific enzyme responsible for this step is **Phenylethanolamine N-methyltransferase (PNMT)**. This enzyme transfers a methyl group from S-adenosylmethionine (SAMe) to the nitrogen atom of norepinephrine. This reaction is highly dependent on high concentrations of **cortisol**, which reaches the adrenal medulla via the intra-adrenal portal system to induce the expression of PNMT. 2. **Why Other Options are Incorrect:** * **Decarboxylation:** This occurs earlier in the catecholamine synthesis pathway when **L-Dopa** is converted to **Dopamine** by the enzyme Dopa-decarboxylase. * **Oxidation:** This is a degradative process. **Monoamine Oxidase (MAO)** oxidizes catecholamines into their respective metabolites (like VMA). * **Sulphation:** This is a Phase II conjugation reaction involved in the metabolism and excretion of various drugs and hormones, but not in the synthesis of epinephrine. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** The conversion of Tyrosine to L-Dopa by **Tyrosine Hydroxylase** is the rate-limiting step in catecholamine synthesis. * **Storage:** Norepinephrine is stored in vesicles, but the conversion to Epinephrine happens in the **cytosol**; Epinephrine then re-enters vesicles for storage. * **Pheochromocytoma:** Tumors arising outside the adrenal gland (paragangliomas) often lack PNMT and thus secrete primarily Norepinephrine, whereas adrenal tumors secrete both.

Q: Which one of the following is not an alpha-adrenoceptor agonist?

Methyldopa. **Explanation:** The core concept tested here is the difference between a **direct agonist** and a **prodrug**. **Why Methyldopa is the correct answer:** Methyldopa is not an alpha-adrenoceptor agonist itself. Instead, it is a **prodrug**. Once it crosses the blood-brain barrier, it is converted into **$\alpha$-methylnorepinephrine** by the enzymes DOPA decarboxylase and Dopamine $\beta$-hydroxylase. It is this active metabolite, not Methyldopa, that acts as a potent agonist at central $\alpha_2$ receptors to decrease sympathetic outflow. **Analysis of Incorrect Options:** * **Clonidine:** A direct-acting, selective $\alpha_2$-adrenoceptor agonist. It acts on the imidazoline receptors and $\alpha_2$ receptors in the nucleus tractus solitarius to reduce blood pressure. * **Guanabenz and Guanfacine:** These are also direct-acting central $\alpha_2$-adrenoceptor agonists. They share a similar mechanism of action to clonidine but are used less frequently in clinical practice. **High-Yield NEET-PG Clinical Pearls:** 1. **Drug of Choice:** Methyldopa remains the drug of choice for **Pregnancy-Induced Hypertension (PIH)** due to its long-term safety profile for the fetus. 2. **Side Effects:** A classic side effect of Methyldopa is a **positive Coombs test**, which may rarely lead to hemolytic anemia. 3. **Rebound Hypertension:** Abrupt withdrawal of direct $\alpha_2$ agonists like Clonidine can lead to a hypertensive crisis due to a sudden surge in catecholamines. 4. **Mechanism:** All four drugs listed decrease sympathetic tone, but only Methyldopa requires metabolic conversion to do so.

Q: Cholinergic drugs are used in all the following conditions except?

Bradycardia. **Explanation:** The correct answer is **Bradycardia** because cholinergic drugs (parasympathomimetics) stimulate the M2 receptors in the heart, leading to a decrease in heart rate (negative chronotropy). Therefore, they are **contraindicated** in bradycardia. Instead, anticholinergic drugs like Atropine are the treatment of choice for symptomatic bradycardia. **Analysis of Options:** * **Cobra Bite:** Cobra venom contains post-synaptic neurotoxins that block Nicotinic receptors (Nm) at the neuromuscular junction, causing paralysis. Cholinesterase inhibitors like **Neostigmine** are used to increase Acetylcholine levels, which compete with the toxin to reverse muscle weakness. * **Postoperative paralytic ileus:** Cholinergic agonists (e.g., **Bethanechol**) or cholinesterase inhibitors (e.g., **Neostigmine**) stimulate M3 receptors on the gastrointestinal smooth muscle, promoting motility and helping resolve non-obstructive ileus or urinary retention. * **Glaucoma:** Miotics like **Pilocarpine** cause contraction of the iris sphincter (miosis) and the ciliary muscle. This opens the trabecular meshwork, facilitating the drainage of aqueous humor and reducing intraocular pressure. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Atropine is the DOC for sinus bradycardia and organophosphate poisoning. * **Bethanechol** is the preferred cholinergic for bladder atony because it has negligible effects on the heart (M2) but high selectivity for the gut and bladder (M3). * **Neostigmine** is always co-administered with Glycopyrrolate or Atropine to prevent unwanted muscarinic side effects (like bradycardia) when reversing neuromuscular blockade.

Q: A drug 'X' is an alpha adrenergic blocker but paradoxically produces vasoconstriction. What is drug 'X'?

Ergotamine. The correct answer is **Ergotamine**. **1. Why Ergotamine is the correct answer:** Ergotamine is a non-selective alpha-adrenergic blocker, but it is unique because it acts as a **partial agonist** at alpha-receptors and 5-HT receptors [1]. While it can block the effects of stronger agonists (like norepinephrine), its intrinsic activity at these receptors causes significant **direct smooth muscle contraction** [1]. This results in peripheral vasoconstriction, which is the "paradoxical" effect referred to in the question [3]. This property is clinically utilized to treat acute migraine attacks by constricting dilated cerebral vessels [4]. **2. Analysis of Incorrect Options:** * **Phenoxybenzamine (A):** An irreversible, non-selective alpha-blocker [3]. It causes profound vasodilation and is used in the management of pheochromocytoma [2]. It does not possess vasoconstrictive properties. * **Prazosin (C):** A highly selective alpha-1 blocker. It causes vasodilation and is used for hypertension and BPH. It is notorious for the "first-dose phenomenon" (postural hypotension). * **Tolazoline (D):** An imidazoline derivative with competitive alpha-blocking activity. While it has some histamine-like effects, it primarily acts as a vasodilator and was historically used in persistent pulmonary hypertension of the newborn. **3. High-Yield Clinical Pearls for NEET-PG:** * **Ergotism (St. Anthony’s Fire):** Overdosage or chronic use of ergotamine leads to severe, persistent vasoconstriction resulting in gangrene of the extremities. * **Contraindication:** Ergotamine is strictly contraindicated in patients with Peripheral Vascular Disease (PVD) and Coronary Artery Disease (CAD) due to its vasoconstrictive nature [4]. * **Drug Interaction:** Avoid combining ergotamine with Triptans (5-HT 1B/1D agonists) within 24 hours, as this can lead to additive vasospasm.

Question 1

Exogenous adrenaline is metabolized by which of the following?

Accepted Answer

COMT (Catechol-O-methyltransferase)

Answer

Acetyltransferase

Answer

Reuptake

Answer

AchE (Acetylcholinesterase)

Question 2

Which of the following anticholinesterase agents is derived from a natural source?

Accepted Answer

Physostigmine

Answer

Neostigmine

Answer

Pyridostigmine

Answer

Tacrine

Question 3

Which of the following is a selective α2 agonist?

Accepted Answer

Clonidine

Answer

Prazosin

Answer

Adrenaline

Answer

Propranolol

Question 4

Which of the following cholinomimetics activates both muscarinic and nicotinic receptors?

Accepted Answer

Carbachol

Answer

Methacholine

Answer

Bethanechol

Answer

Pilocarpine

Question 5

Non-selective beta-blockers are contraindicated in patients with diabetes due to which of the following reasons?

Accepted Answer

Hypoglycemic unawareness

Answer

Hyperglycemia

Answer

Tachycardia

Answer

Hypotension

Question 6

Which of the following is the most reliable clinical endpoint to indicate adequate atropinization in organophosphorus poisoning?

Accepted Answer

Absence of pulmonary secretions

Answer

Pupillary dilation

Answer

Control of diarrhea

Answer

Heart rate more than or equal to 100 beats per minute

Question 7

Conversion of norepinephrine to epinephrine occurs by which process?

Accepted Answer

Methylation

Answer

Decarboxylation

Answer

Oxidation

Answer

Sulphation

Question 8

Which one of the following is not an alpha-adrenoceptor agonist?

Accepted Answer

Methyldopa

Answer

Clonidine

Answer

Guanabenz

Answer

Guanfacine

Question 9

Cholinergic drugs are used in all the following conditions except?

Accepted Answer

Bradycardia

Answer

Cobra Bite

Answer

Postoperative paralytic ileus

Answer

Glaucoma

Question 10

A drug 'X' is an alpha adrenergic blocker but paradoxically produces vasoconstriction. What is drug 'X'?

Accepted Answer

Ergotamine

Answer

Phenoxybenzamine

Answer

Prazosin

Answer

Tolazoline

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?